Phase I RVC With Ocriplasmin for CRVO

计划入组 4 人 · 首次发布于 2016 年 4 月 21 日

Lucentis for Central Retinal Vein Occlusion (CRVO)

计划入组 20 人 · 首次发布于 2006 年 12 月 4 日

The Effectiveness of Intravitreal Avastin Injection for CRVO

计划入组 68 人 · 首次发布于 2012 年 9 月 3 日

CVO-035

CRO-67

CRV-101

CervoMed

United States

CLINIC CRYO ESTHETIC

France

CREO MEDICAL LIMITED

United Kingdom

Roche's Vabysmo Demonstrates Sustained Efficacy in Retinal Vein Occlusion with Extended Dosing Intervals

Chugai's Vabysmo Receives Japanese Approval for Retinal Vein Occlusion Treatment

CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies by Targeting Neurodegenerative Activity